Sanofi announced plans to expand its ‘insulins Valyou Savings Program’ that will further reduce the cost of Sanofi insulins for patients with diabetes.
The Insulins Valyou Savings Program was launched a year ago to set the price for cash-paying patients at $99 for one 10 mL vial or $149 for one box of pens. Now, the expanded program will allow patients to pay $99 for up to 10 boxes of pens and/or 10mLs vials per month. Patients of any income level can participate in the Insulins Valyou Savings Program if they do not qualify for other patient assistance programs or if they face high out-of-pocket costs for their insulin.
Patients must have a valid prescription for Sanofi insulins: Admelog (insulin lispro 100 Units/mL), Toujeo (insulin glargine 300 Units/mL), Apidra (insulin gluglisine [dNA origin]), Lantus (insulin glargine 100 Units/mL). The program does not include Sanofi’s combination insulin product, Soliqua 100/33. With the savings card, prices are guaranteed for 12 consecutive monthly fills.
Medicare/Medicaid patients or those under similar federal or state programs are not eligible for this savings program.
“By giving those who require both long-acting and/or mealtime insulins or use more than one box of pens or one vial per month access to their insulins for one flat price, we aim to help limit the burden on the individuals who have high out-of-pocket costs at the pharmacy counter,” stated Michelle Carnahan, Head of North America Primary Care at Sanofi.
For more information visit Admelog.com.
This article originally appeared on MPR